Symptomatic management of calciphylaxis: a case series and review of the literature
- PMID: 16877187
- DOI: 10.1016/j.jpainsymman.2006.03.009
Symptomatic management of calciphylaxis: a case series and review of the literature
Abstract
Calciphylaxis, or calcific uremic arteriopathy, is a rare complication of end-stage renal impairment. It is characterized by the development of small vessel vasculopathy with subcutaneous necrosis and ulceration. Intense pain and cutaneous hyperesthesia are prominent features. Mortality rates are high, and the resulting morbidity is significant. While symptomatic management is the mainstay of treatment, it can be challenging. We describe the symptomatic management of a series of three patients with calciphylaxis. Particular emphasis is placed on the use of multimodal analgesia with high-dose opioids, ketamine, and benzodiazepines and on the use of preemptive analgesia.
Comment in
-
Use of ketamine for ischemic pain in end-stage renal failure.J Pain Symptom Manage. 2008 Mar;35(3):232-4. doi: 10.1016/j.jpainsymman.2007.10.002. Epub 2008 Jan 16. J Pain Symptom Manage. 2008. PMID: 18201864 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
